Discover
Stocks
Consumer Goods
SWTX
SWTX
SpringWorks Therapeutics Inc
27.53
0.77 (2.88%)
Delayed Prices By NASDAQ,
in USD
Market Closed
Invest
Buy
SWTX
SpringWorks Therapeutics Inc
Overview
Stats
Chart
Analysis
News
Invest
Buy
FINANCIAL SUMMARY
For the quarter ended 31/3/2023, SpringWorks Therapeutics Inc's revenues decreased by NaN and amounted to 0.00. Net income increased by 1.02% to -73.42M. Net assets decreased by 9.18% to 506.92M and EPS increased from -1.19 to -1.18.
SWTX's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
-26.04%
Operating Margin
N/A
Return On Investment
-31.52%